Upcoming event

EAU21 congress sessions

For our 36th Annual Congress, we are hosting a Virtual Congress that will bring Europe’s largest network of urological experts to your own screen. The comprehensive scientific programme includes live surgery, state-of-the-art lectures, case discussions and debates.

Found below is the list of congress sessions featuring topics related to prostate cancer. Don’t miss the highlighted abstracts recommended by the UROONCO Editorial Board.

Friday 9 July

10:15 – 10:30 Virtual Room 3 Game changing session 1

10:30 – 12:00 Virtual room 1 Nightmare session: PCa early detection

12:00 – 12:45 Virtual room 2 Techniques to evolve radical prostatectomy

13:45 – 14:45 Virtual room 2 Update on prostate cancer screening 2021

14:00 – 15:00 Virtual Room 8 Guidelines

15:00 – 16:00 Virtual room 1 Basic research in prostate cancer and potential clinical impact

16:30 – 17:30 Virtual room 2 Active Surveillance for intermediate risk prostate cancer: What urologist and patients should know

18:00 – 19:00 Virtual Room 8 Cell biology, biomarkers and novel therapies in prostate cancer

Saturday 10 July

11:15 – 11:45 Virtual room 1 Game changing session 5

12:30 – 13:15 Virtual Room 4 Improving outcomes following robotic cystectomy

13:15 – 14:15 Virtual room 2 Germline genetic testing and clinical consequences for patients and relatives in onco-urology

13:15 – 14:15 Virtual Room 3 Urinary biomarkers: Are we there yet

16:00 – 17:00 Virtual Room 7 Best of EAU21 poster abstracts

Sunday 11 July

11:45 – 13:15 Virtual room 1 Treatment for metastatic hormone-sensitive prostate cancer

15:00 – 16:00 Virtual room 2 Guideline Session II: Prostate cancer – cN+ in newly diagnosed patients

15:00 – 16:00 Virtual Room 4 Complications/solutions of robot-assisted urologic surgery: Quick answers

16:00 – 17:00 Virtual Room 6 Metastatic prostate cancer

P0836 External validation of a nomogram for predicting 68Ga-PSMA PET/CT detection rate in patients with prostate cancer recurrence. A clinical tool to guide physicians before suggesting 68Ga-PSMA PET/CT, L. Bianchi, Bologna (IT)

P0855 The obesity paradox in metastatic castration resistant prostate cancer, G.O. Cirulli, Roma (IT)

16:30 – 17:30 Virtual room 1 Treatment sequencing in metastatic prostate cancer

17:00 – 17:30 Virtual Room 7 Clinical trials

P0866 Impact of peri-operative testosterone levels on oncological and functional outcomes in radical prostatectomy (ENFORCE trial), D.J.H. Baas, Utrecht (NL)

17:15 – 18:00 Virtual room 2 Augmented reality in robotic urological surgery

Monday 12 July

09:30 – 10:30 Virtual Room 9 Prostate cancer detection by MR, PET and Micro-US imaging

10:30 – 11:30 Virtual Room 10 Prostate cancer biopsy protocols and methods of targeting

11:30 – 12:30 Virtual Room 9 Prostate cancer screening, biopsy indication protocols and markers

12:00 – 13:00 Virtual Room 5 Joint session of the EAU and the Advanced Prostate Cancer Consensus (APCCC)

12:30 – 13:30 Virtual Room 10 Active surveillance and focal therapy: Evolving concepts and long term outcome

P1044 Development of the STRATified CANcer Surveillance protocol for men with favourable-risk prostate cancer, A. Light, Southwark (GB)

13:30 – 14:30 Virtual Room 6 7th ESO Prostate Cancer observatory: Innovations and care in the next 12 months

13:30 – 14:30 Virtual Room 9 Radical prostatectomy: Long-term outcome and how we can do better

P1102 Retzius-sparing vs. conventional robotic assisted radical prostatectomy in a prospective, randomised trial – early functional outcome and quality of life, V.S. Schütz, Heidelberg (DE)

14:30 – 15:30 Virtual Room 5 PIONEER prostate cancer platform

14:30 – 15:30 Virtual Room 10 Functional outcome of radical prostatectomy and how we can do better

15:30 – 16:00 Virtual room 2 Focal diagnosis and treatment

15:30 – 16:30 Virtual Room 9 Detection of recurrence and salvage treatment options after primary treatment for prostate cancer

16:00 – 17:30 Virtual room 1 Controversies in onco-urology

16:00 – 17:30 Virtual Room 3 Ready for take-off: Molecular markers for clinical management of urological malignancies

16:30 – 17:30 Virtual Room 10 How to manage high risk and advanced prostate cancer?

17:30 – 19:30 Virtual room 2 Best of EAU21 session